0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Cannabidiol (CBD) Ingredient- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032
Published Date: 2026-06-15
|
Report Code: QYRE-Auto-27Z14464
Home | Market Reports
Global Cannabidiol CBD Ingredient Market Research Report 2023
BUY CHAPTERS

Cannabidiol (CBD) Ingredient- Global Market Share and Ranking, Overall Sales and Demand Forecast 2026-2032

Code: QYRE-Auto-27Z14464
Report
2026-06-15
Pages:165
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Cannabidiol (CBD) Ingredient- Market

The global market for Cannabidiol (CBD) Ingredient was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
The potential shifts in the 2025 U.S. tariff framework pose substantial volatility risks to global markets. This report provides a comprehensive assessment of recent tariff adjustments and international strategic countermeasures on Cannabidiol (CBD) Ingredient cross-border industrial footprints, capital allocation patterns, regional economic interdependencies, and supply chain reconfigurations.
CBD (cannabidiol) is a naturally occurring compound found in cannabis plants, including hemp and marijuana. It is one of many cannabinoids present in these plants. CBD is known for its potential therapeutic benefits and is commonly used in various products, such as oils, tinctures, capsules, creams, and edibles.
The North American market for Cannabidiol (CBD) Ingredient was valued at US$ million in 2025 and is projected to reach US$ million by 2032, at a CAGR of % from 2026 to 2032.
The Asia-Pacific market for Cannabidiol (CBD) Ingredient was valued at $ million in 2025 and is projected to climb to US$ million by 2032, at a CAGR of % from 2026 to 2032.
The European market for Cannabidiol (CBD) Ingredient was valued at $ million in 2025 and is projected to total US$ million by 2032, at a CAGR of % from 2026 to 2032.
The global key companies in the Cannabidiol (CBD) Ingredient market include Vantage Hemp, Eurofins, EndoPure, Mile High Labs, KLERSUN, KND Labs, Jordan Process, GVB Biopharma, Purisys, Sanobiotec, etc. In 2025, the five largest players accounted for approximately % of revenue.
This report provides a comprehensive view of the global market for Cannabidiol (CBD) Ingredient, covering total sales volume, sales revenue, pricing, the market share and ranking of key companies, along with analyses by region & country, by Type, and by Application.
The Cannabidiol (CBD) Ingredient market size, estimations, and forecasts are presented in terms of sales volume (Tons) and revenue ($ millions), with 2025 as the base year and historical and forecast data from 2021 to 2032. The report combines quantitative and qualitative analysis to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current marketplace, and make informed business decisions regarding Cannabidiol (CBD) Ingredient.
Market Segmentation

Scope of Cannabidiol (CBD) Ingredient- Market Report

Report Metric Details
Report Name Cannabidiol (CBD) Ingredient- Market
Segment by Type
  • Natural Marijuana-Based
  • Synthetic
Segment by Application
  • Food and Beverages
  • Personal Care and Cosmetics
  • Nutraceuticals
  • API
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Vantage Hemp, Eurofins, EndoPure, Mile High Labs, KLERSUN, KND Labs, Jordan Process, GVB Biopharma, Purisys, Sanobiotec, Folium Biosciences, Colombian Golden, Averix Bio, LLC, Healthcann, DSM, Veranova, Caesar & Loretz GmbH, Recipharm, Brains Bioceutical, Bedrocan, BIOVECTRA Inc., Biosyyd, UAB, Kinetochem
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the scope of the report and the global market size (value, volume, and price). It also summarizes market dynamics and Recent Developments; identifies key drivers and restraints; outlines challenges and risks for manufacturers; reviews relevant industry policies and U.S. tariff implications.
  • Chapter 2: Provides a detailed analysis of the Cannabidiol (CBD) Ingredient manufacturers' competitive landscape—including pricing, sales and revenue shares, Recent Developments plans, and mergers and acquisitions (M&A).
  • Chapter 3: Analyzes market segmentation by Type, presenting the size and growth potential of each segment to help readers identify blue-ocean opportunities.
  • Chapter 4: Analyzes market segmentation by Application, presenting the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
  • Chapter 5: Presents Cannabidiol (CBD) Ingredient sales and revenue at the regional level. It offers a quantitative assessment of market size and growth potential by region and summarizes market development, future prospects, addressable space, and country-level market size worldwide.
  • Chapter 6: Presents Cannabidiol (CBD) Ingredient sales and revenue at the country level. It provides segmented data by Type and by Application for each country/region.
  • Chapter 7: Profiles key players, detailing the main companies' product sales, revenue, pricing, gross margin, product portfolios, Recent Developments, etc.
  • Chapter 8: Analyzes the industry value chain, including upstream suppliers and downstream applications/customers.
  • Chapter 9: Conclusion.

FAQ for this report

Who are the main players in the Cannabidiol (CBD) Ingredient- Market report?

Ans: The main players in the Cannabidiol (CBD) Ingredient- Market are Vantage Hemp, Eurofins, EndoPure, Mile High Labs, KLERSUN, KND Labs, Jordan Process, GVB Biopharma, Purisys, Sanobiotec, Folium Biosciences, Colombian Golden, Averix Bio, LLC, Healthcann, DSM, Veranova, Caesar & Loretz GmbH, Recipharm, Brains Bioceutical, Bedrocan, BIOVECTRA Inc., Biosyyd, UAB, Kinetochem

What are the Application segmentation covered in the Cannabidiol (CBD) Ingredient- Market report?

Ans: The Applications covered in the Cannabidiol (CBD) Ingredient- Market report are Food and Beverages, Personal Care and Cosmetics, Nutraceuticals, API

What are the Type segmentation covered in the Cannabidiol (CBD) Ingredient- Market report?

Ans: The Types covered in the Cannabidiol (CBD) Ingredient- Market report are Natural Marijuana-Based, Synthetic

1 Market Overview
1.1 Cannabidiol (CBD) Ingredient Product Introduction
1.2 Global Cannabidiol (CBD) Ingredient Market Size Forecast
1.2.1 Global Cannabidiol (CBD) Ingredient Sales Value (2021–2032)
1.2.2 Global Cannabidiol (CBD) Ingredient Sales Volume (2021–2032)
1.2.3 Global Cannabidiol (CBD) Ingredient Sales Price (2021–2032)
1.3 Cannabidiol (CBD) Ingredient Market Trends & Drivers
1.3.1 Cannabidiol (CBD) Ingredient Industry Trends
1.3.2 Cannabidiol (CBD) Ingredient Market Drivers & Opportunities
1.3.3 Cannabidiol (CBD) Ingredient Market Challenges
1.3.4 Cannabidiol (CBD) Ingredient Market Restraints
1.3.5 Impact of U.S. Tariffs
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Cannabidiol (CBD) Ingredient Players Revenue Ranking (2025)
2.2 Global Cannabidiol (CBD) Ingredient Revenue by Company (2021–2026)
2.3 Global Cannabidiol (CBD) Ingredient Sales Volume Ranking of Players (2025)
2.4 Global Cannabidiol (CBD) Ingredient Sales Volume by Company (2021–2026)
2.5 Global Cannabidiol (CBD) Ingredient Average Price by Company (2021–2026)
2.6 Key Manufacturers Cannabidiol (CBD) Ingredient Manufacturing Base and Headquarters
2.7 Key Manufacturers Cannabidiol (CBD) Ingredient Product Offerings
2.8 Key Manufacturers Start of Mass Production of Cannabidiol (CBD) Ingredient
2.9 Cannabidiol (CBD) Ingredient Market Competitive Analysis
2.9.1 Cannabidiol (CBD) Ingredient Market Concentration Rate (2021–2026)
2.9.2 Global 5 and 10 Largest Manufacturers by Cannabidiol (CBD) Ingredient Revenue in 2025
2.9.3 Global Companies by Tier (Tier 1, Tier 2, Tier 3), based on Cannabidiol (CBD) Ingredient revenue, 2025
2.10 Mergers & Acquisitions and Expansion
3 Segmentation Cannabidiol (CBD) Ingredient Market Classification
3.1 Introduction by Type
3.1.1 Natural Marijuana-Based
3.1.2 Synthetic
3.1.3 Global Cannabidiol (CBD) Ingredient Sales Value by Type
3.1.3.1 Global Cannabidiol (CBD) Ingredient Sales Value by Type (2021 vs 2025 vs 2032)
3.1.3.2 Global Cannabidiol (CBD) Ingredient Sales Value, by Type (2021–2032)
3.1.3.3 Global Cannabidiol (CBD) Ingredient Sales Value, by Type (%), 2021–2032
3.1.4 Global Cannabidiol (CBD) Ingredient Sales Volume by Type
3.1.4.1 Global Cannabidiol (CBD) Ingredient Sales Volume by Type (2021 vs 2025 vs 2032)
3.1.4.2 Global Cannabidiol (CBD) Ingredient Sales Volume, by Type (2021–2032)
3.1.4.3 Global Cannabidiol (CBD) Ingredient Sales Volume, by Type (%), 2021–2032
3.1.5 Global Cannabidiol (CBD) Ingredient Average Price by Type (2021–2032)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Food and Beverages
4.1.2 Personal Care and Cosmetics
4.1.3 Nutraceuticals
4.1.4 API
4.2 Global Cannabidiol (CBD) Ingredient Sales Value by Application
4.2.1 Global Cannabidiol (CBD) Ingredient Sales Value by Application (2021 vs 2025 vs 2032)
4.2.2 Global Cannabidiol (CBD) Ingredient Sales Value, by Application (2021–2032)
4.2.3 Global Cannabidiol (CBD) Ingredient Sales Value, by Application (%), 2021–2032
4.3 Global Cannabidiol (CBD) Ingredient Sales Volume by Application
4.3.1 Global Cannabidiol (CBD) Ingredient Sales Volume by Application (2021 vs 2025 vs 2032)
4.3.2 Global Cannabidiol (CBD) Ingredient Sales Volume, by Application (2021–2032)
4.3.3 Global Cannabidiol (CBD) Ingredient Sales Volume, by Application (%), 2021–2032
4.4 Global Cannabidiol (CBD) Ingredient Average Price by Application (2021–2032)
5 Segmentation by Region
5.1 Global Cannabidiol (CBD) Ingredient Sales Value by Region
5.1.1 Global Cannabidiol (CBD) Ingredient Sales Value by Region: 2021 vs 2025 vs 2032
5.1.2 Global Cannabidiol (CBD) Ingredient Sales Value by Region (2021–2026)
5.1.3 Global Cannabidiol (CBD) Ingredient Sales Value by Region (2027–2032)
5.1.4 Global Cannabidiol (CBD) Ingredient Sales Value by Region (%), 2021–2032
5.2 Global Cannabidiol (CBD) Ingredient Sales Volume by Region
5.2.1 Global Cannabidiol (CBD) Ingredient Sales Volume by Region: 2021 vs 2025 vs 2032
5.2.2 Global Cannabidiol (CBD) Ingredient Sales Volume by Region (2021–2026)
5.2.3 Global Cannabidiol (CBD) Ingredient Sales Volume by Region (2027–2032)
5.2.4 Global Cannabidiol (CBD) Ingredient Sales Volume by Region (%), 2021–2032
5.3 Global Cannabidiol (CBD) Ingredient Average Price by Region (2021–2032)
5.4 North America
5.4.1 North America Cannabidiol (CBD) Ingredient Sales Value, 2021–2032
5.4.2 North America Cannabidiol (CBD) Ingredient Sales Value by Country (%), 2025 vs 2032
5.5 Europe
5.5.1 Europe Cannabidiol (CBD) Ingredient Sales Value, 2021–2032
5.5.2 Europe Cannabidiol (CBD) Ingredient Sales Value by Country (%), 2025 vs 2032
5.6 Asia Pacific
5.6.1 Asia Pacific Cannabidiol (CBD) Ingredient Sales Value, 2021–2032
5.6.2 Asia Pacific Cannabidiol (CBD) Ingredient Sales Value by Region (%), 2025 vs 2032
5.7 South America
5.7.1 South America Cannabidiol (CBD) Ingredient Sales Value, 2021–2032
5.7.2 South America Cannabidiol (CBD) Ingredient Sales Value by Country (%), 2025 vs 2032
5.8 Middle East & Africa
5.8.1 Middle East & Africa Cannabidiol (CBD) Ingredient Sales Value, 2021–2032
5.8.2 Middle East & Africa Cannabidiol (CBD) Ingredient Sales Value by Country (%), 2025 vs 2032
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Cannabidiol (CBD) Ingredient Sales Value Growth Trends, 2021 vs 2025 vs 2032
6.2 Key Countries/Regions Cannabidiol (CBD) Ingredient Sales Value and Sales Volume
6.2.1 Key Countries/Regions Cannabidiol (CBD) Ingredient Sales Value, 2021–2032
6.2.2 Key Countries/Regions Cannabidiol (CBD) Ingredient Sales Volume, 2021–2032
6.3 United States
6.3.1 United States Cannabidiol (CBD) Ingredient Sales Value, 2021–2032
6.3.2 United States Cannabidiol (CBD) Ingredient Sales Value by Type (%), 2025 vs 2032
6.3.3 United States Cannabidiol (CBD) Ingredient Sales Value by Application, 2025 vs 2032
6.4 Europe
6.4.1 Europe Cannabidiol (CBD) Ingredient Sales Value, 2021–2032
6.4.2 Europe Cannabidiol (CBD) Ingredient Sales Value by Type (%), 2025 vs 2032
6.4.3 Europe Cannabidiol (CBD) Ingredient Sales Value by Application, 2025 vs 2032
6.5 China
6.5.1 China Cannabidiol (CBD) Ingredient Sales Value, 2021–2032
6.5.2 China Cannabidiol (CBD) Ingredient Sales Value by Type (%), 2025 vs 2032
6.5.3 China Cannabidiol (CBD) Ingredient Sales Value by Application, 2025 vs 2032
6.6 Japan
6.6.1 Japan Cannabidiol (CBD) Ingredient Sales Value, 2021–2032
6.6.2 Japan Cannabidiol (CBD) Ingredient Sales Value by Type (%), 2025 vs 2032
6.6.3 Japan Cannabidiol (CBD) Ingredient Sales Value by Application, 2025 vs 2032
6.7 South Korea
6.7.1 South Korea Cannabidiol (CBD) Ingredient Sales Value, 2021–2032
6.7.2 South Korea Cannabidiol (CBD) Ingredient Sales Value by Type (%), 2025 vs 2032
6.7.3 South Korea Cannabidiol (CBD) Ingredient Sales Value by Application, 2025 vs 2032
6.8 Southeast Asia
6.8.1 Southeast Asia Cannabidiol (CBD) Ingredient Sales Value, 2021–2032
6.8.2 Southeast Asia Cannabidiol (CBD) Ingredient Sales Value by Type (%), 2025 vs 2032
6.8.3 Southeast Asia Cannabidiol (CBD) Ingredient Sales Value by Application, 2025 vs 2032
6.9 India
6.9.1 India Cannabidiol (CBD) Ingredient Sales Value, 2021–2032
6.9.2 India Cannabidiol (CBD) Ingredient Sales Value by Type (%), 2025 vs 2032
6.9.3 India Cannabidiol (CBD) Ingredient Sales Value by Application, 2025 vs 2032
7 Company Profiles
7.1 Vantage Hemp
7.1.1 Vantage Hemp Company Information
7.1.2 Vantage Hemp Introduction and Business Overview
7.1.3 Vantage Hemp Cannabidiol (CBD) Ingredient Sales, Revenue, Price and Gross Margin (2021–2026)
7.1.4 Vantage Hemp Cannabidiol (CBD) Ingredient Product Offerings
7.1.5 Vantage Hemp Recent Developments
7.2 Eurofins
7.2.1 Eurofins Company Information
7.2.2 Eurofins Introduction and Business Overview
7.2.3 Eurofins Cannabidiol (CBD) Ingredient Sales, Revenue, Price and Gross Margin (2021–2026)
7.2.4 Eurofins Cannabidiol (CBD) Ingredient Product Offerings
7.2.5 Eurofins Recent Developments
7.3 EndoPure
7.3.1 EndoPure Company Information
7.3.2 EndoPure Introduction and Business Overview
7.3.3 EndoPure Cannabidiol (CBD) Ingredient Sales, Revenue, Price and Gross Margin (2021–2026)
7.3.4 EndoPure Cannabidiol (CBD) Ingredient Product Offerings
7.3.5 EndoPure Recent Developments
7.4 Mile High Labs
7.4.1 Mile High Labs Company Information
7.4.2 Mile High Labs Introduction and Business Overview
7.4.3 Mile High Labs Cannabidiol (CBD) Ingredient Sales, Revenue, Price and Gross Margin (2021–2026)
7.4.4 Mile High Labs Cannabidiol (CBD) Ingredient Product Offerings
7.4.5 Mile High Labs Recent Developments
7.5 KLERSUN
7.5.1 KLERSUN Company Information
7.5.2 KLERSUN Introduction and Business Overview
7.5.3 KLERSUN Cannabidiol (CBD) Ingredient Sales, Revenue, Price and Gross Margin (2021–2026)
7.5.4 KLERSUN Cannabidiol (CBD) Ingredient Product Offerings
7.5.5 KLERSUN Recent Developments
7.6 KND Labs
7.6.1 KND Labs Company Information
7.6.2 KND Labs Introduction and Business Overview
7.6.3 KND Labs Cannabidiol (CBD) Ingredient Sales, Revenue, Price and Gross Margin (2021–2026)
7.6.4 KND Labs Cannabidiol (CBD) Ingredient Product Offerings
7.6.5 KND Labs Recent Developments
7.7 Jordan Process
7.7.1 Jordan Process Company Information
7.7.2 Jordan Process Introduction and Business Overview
7.7.3 Jordan Process Cannabidiol (CBD) Ingredient Sales, Revenue, Price and Gross Margin (2021–2026)
7.7.4 Jordan Process Cannabidiol (CBD) Ingredient Product Offerings
7.7.5 Jordan Process Recent Developments
7.8 GVB Biopharma
7.8.1 GVB Biopharma Company Information
7.8.2 GVB Biopharma Introduction and Business Overview
7.8.3 GVB Biopharma Cannabidiol (CBD) Ingredient Sales, Revenue, Price and Gross Margin (2021–2026)
7.8.4 GVB Biopharma Cannabidiol (CBD) Ingredient Product Offerings
7.8.5 GVB Biopharma Recent Developments
7.9 Purisys
7.9.1 Purisys Company Information
7.9.2 Purisys Introduction and Business Overview
7.9.3 Purisys Cannabidiol (CBD) Ingredient Sales, Revenue, Price and Gross Margin (2021–2026)
7.9.4 Purisys Cannabidiol (CBD) Ingredient Product Offerings
7.9.5 Purisys Recent Developments
7.10 Sanobiotec
7.10.1 Sanobiotec Company Information
7.10.2 Sanobiotec Introduction and Business Overview
7.10.3 Sanobiotec Cannabidiol (CBD) Ingredient Sales, Revenue, Price and Gross Margin (2021–2026)
7.10.4 Sanobiotec Cannabidiol (CBD) Ingredient Product Offerings
7.10.5 Sanobiotec Recent Developments
7.11 Folium Biosciences
7.11.1 Folium Biosciences Company Information
7.11.2 Folium Biosciences Introduction and Business Overview
7.11.3 Folium Biosciences Cannabidiol (CBD) Ingredient Sales, Revenue, Price and Gross Margin (2021–2026)
7.11.4 Folium Biosciences Cannabidiol (CBD) Ingredient Product Offerings
7.11.5 Folium Biosciences Recent Developments
7.12 Colombian Golden
7.12.1 Colombian Golden Company Information
7.12.2 Colombian Golden Introduction and Business Overview
7.12.3 Colombian Golden Cannabidiol (CBD) Ingredient Sales, Revenue, Price and Gross Margin (2021–2026)
7.12.4 Colombian Golden Cannabidiol (CBD) Ingredient Product Offerings
7.12.5 Colombian Golden Recent Developments
7.13 Averix Bio, LLC
7.13.1 Averix Bio, LLC Company Information
7.13.2 Averix Bio, LLC Introduction and Business Overview
7.13.3 Averix Bio, LLC Cannabidiol (CBD) Ingredient Sales, Revenue, Price and Gross Margin (2021–2026)
7.13.4 Averix Bio, LLC Cannabidiol (CBD) Ingredient Product Offerings
7.13.5 Averix Bio, LLC Recent Developments
7.14 Healthcann
7.14.1 Healthcann Company Information
7.14.2 Healthcann Introduction and Business Overview
7.14.3 Healthcann Cannabidiol (CBD) Ingredient Sales, Revenue, Price and Gross Margin (2021–2026)
7.14.4 Healthcann Cannabidiol (CBD) Ingredient Product Offerings
7.14.5 Healthcann Recent Developments
7.15 DSM
7.15.1 DSM Company Information
7.15.2 DSM Introduction and Business Overview
7.15.3 DSM Cannabidiol (CBD) Ingredient Sales, Revenue, Price and Gross Margin (2021–2026)
7.15.4 DSM Cannabidiol (CBD) Ingredient Product Offerings
7.15.5 DSM Recent Developments
7.16 Veranova
7.16.1 Veranova Company Information
7.16.2 Veranova Introduction and Business Overview
7.16.3 Veranova Cannabidiol (CBD) Ingredient Sales, Revenue, Price and Gross Margin (2021–2026)
7.16.4 Veranova Cannabidiol (CBD) Ingredient Product Offerings
7.16.5 Veranova Recent Developments
7.17 Caesar & Loretz GmbH
7.17.1 Caesar & Loretz GmbH Company Information
7.17.2 Caesar & Loretz GmbH Introduction and Business Overview
7.17.3 Caesar & Loretz GmbH Cannabidiol (CBD) Ingredient Sales, Revenue, Price and Gross Margin (2021–2026)
7.17.4 Caesar & Loretz GmbH Cannabidiol (CBD) Ingredient Product Offerings
7.17.5 Caesar & Loretz GmbH Recent Developments
7.18 Recipharm
7.18.1 Recipharm Company Information
7.18.2 Recipharm Introduction and Business Overview
7.18.3 Recipharm Cannabidiol (CBD) Ingredient Sales, Revenue, Price and Gross Margin (2021–2026)
7.18.4 Recipharm Cannabidiol (CBD) Ingredient Product Offerings
7.18.5 Recipharm Recent Developments
7.19 Brains Bioceutical
7.19.1 Brains Bioceutical Company Information
7.19.2 Brains Bioceutical Introduction and Business Overview
7.19.3 Brains Bioceutical Cannabidiol (CBD) Ingredient Sales, Revenue, Price and Gross Margin (2021–2026)
7.19.4 Brains Bioceutical Cannabidiol (CBD) Ingredient Product Offerings
7.19.5 Brains Bioceutical Recent Developments
7.20 Bedrocan
7.20.1 Bedrocan Company Information
7.20.2 Bedrocan Introduction and Business Overview
7.20.3 Bedrocan Cannabidiol (CBD) Ingredient Sales, Revenue, Price and Gross Margin (2021–2026)
7.20.4 Bedrocan Cannabidiol (CBD) Ingredient Product Offerings
7.20.5 Bedrocan Recent Developments
7.21 BIOVECTRA Inc.
7.21.1 BIOVECTRA Inc. Company Information
7.21.2 BIOVECTRA Inc. Introduction and Business Overview
7.21.3 BIOVECTRA Inc. Cannabidiol (CBD) Ingredient Sales, Revenue, Price and Gross Margin (2021–2026)
7.21.4 BIOVECTRA Inc. Cannabidiol (CBD) Ingredient Product Offerings
7.21.5 BIOVECTRA Inc. Recent Developments
7.22 Biosyyd, UAB
7.22.1 Biosyyd, UAB Company Information
7.22.2 Biosyyd, UAB Introduction and Business Overview
7.22.3 Biosyyd, UAB Cannabidiol (CBD) Ingredient Sales, Revenue, Price and Gross Margin (2021–2026)
7.22.4 Biosyyd, UAB Cannabidiol (CBD) Ingredient Product Offerings
7.22.5 Biosyyd, UAB Recent Developments
7.23 Kinetochem
7.23.1 Kinetochem Company Information
7.23.2 Kinetochem Introduction and Business Overview
7.23.3 Kinetochem Cannabidiol (CBD) Ingredient Sales, Revenue, Price and Gross Margin (2021–2026)
7.23.4 Kinetochem Cannabidiol (CBD) Ingredient Product Offerings
7.23.5 Kinetochem Recent Developments
8 Industry Chain Analysis
8.1 Cannabidiol (CBD) Ingredient Industrial Chain
8.2 Cannabidiol (CBD) Ingredient Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Key Suppliers of Raw Materials
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customer Analysis)
8.5 Sales Model and Sales Channelss
8.5.1 Cannabidiol (CBD) Ingredient Sales Model
8.5.2 Sales Channels
8.5.3 Cannabidiol (CBD) Ingredient Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.1.1 Research Programs/Design
10.1.1.2 Market Size Estimation
10.1.1.3 Market Breakdown and Data Triangulation
10.1.2 Data Source
10.1.2.1 Secondary Sources
10.1.2.2 Primary Sources
10.2 Author Details
10.3 Disclaimer
List of Tables
 Table 1. Cannabidiol (CBD) Ingredient Market Trends
 Table 2. Cannabidiol (CBD) Ingredient Market Drivers & Opportunities
 Table 3. Cannabidiol (CBD) Ingredient Market Challenges
 Table 4. Cannabidiol (CBD) Ingredient Market Restraints
 Table 5. Global Cannabidiol (CBD) Ingredient Revenue by Company (US$ Million), 2021–2026
 Table 6. Global Cannabidiol (CBD) Ingredient Revenue Market Share by Company (2021–2026)
 Table 7. Global Cannabidiol (CBD) Ingredient Sales Volume by Company (Tons), 2021–2026
 Table 8. Global Cannabidiol (CBD) Ingredient Sales Volume Market Share by Company (2021–2026)
 Table 9. Global Market Cannabidiol (CBD) Ingredient Price by Company (US$/Ton), 2021–2026
 Table 10. Key Manufacturers Cannabidiol (CBD) Ingredient Manufacturing Base and Headquarters
 Table 11. Key Manufacturers Cannabidiol (CBD) Ingredient Product Type
 Table 12. Key Manufacturers Start of Mass Production of Cannabidiol (CBD) Ingredient
 Table 13. Global Cannabidiol (CBD) Ingredient Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Top Manufacturers Market Share by Tier (Tier 1, Tier 2, Tier 3), based on Cannabidiol (CBD) Ingredient revenue, 2025
 Table 15. Mergers & Acquisitions and Expansion Plans
 Table 16. Global Cannabidiol (CBD) Ingredient Sales Value by Type: 2021 vs 2025 vs 2032 (US$ Million)
 Table 17. Global Cannabidiol (CBD) Ingredient Sales Value by Type (US$ Million), 2021–2026
 Table 18. Global Cannabidiol (CBD) Ingredient Sales Value by Type (US$ Million), 2027–2032
 Table 19. Global Cannabidiol (CBD) Ingredient Sales Market Share in Value by Type (2021–2026)
 Table 20. Global Cannabidiol (CBD) Ingredient Sales Market Share in Value by Type (2027–2032)
 Table 21. Global Cannabidiol (CBD) Ingredient Sales Volume by Type: 2021 vs 2025 vs 2032 (Tons)
 Table 22. Global Cannabidiol (CBD) Ingredient Sales Volume by Type (Tons), 2021–2026
 Table 23. Global Cannabidiol (CBD) Ingredient Sales Volume by Type (Tons), 2027–2032
 Table 24. Global Cannabidiol (CBD) Ingredient Sales Market Share in Volume by Type (2021–2026)
 Table 25. Global Cannabidiol (CBD) Ingredient Sales Market Share in Volume by Type (2027–2032)
 Table 26. Global Cannabidiol (CBD) Ingredient Price by Type (US$/Ton), 2021–2026
 Table 27. Global Cannabidiol (CBD) Ingredient Price by Type (US$/Ton), 2027–2032
 Table 28. Global Cannabidiol (CBD) Ingredient Sales Value by Application: 2021 vs 2025 vs 2032 (US$ Million)
 Table 29. Global Cannabidiol (CBD) Ingredient Sales Value by Application (US$ Million), 2021–2026
 Table 30. Global Cannabidiol (CBD) Ingredient Sales Value by Application (US$ Million), 2027–2032
 Table 31. Global Cannabidiol (CBD) Ingredient Sales Market Share in Value by Application (2021–2026)
 Table 32. Global Cannabidiol (CBD) Ingredient Sales Market Share in Value by Application (2027–2032)
 Table 33. Global Cannabidiol (CBD) Ingredient Sales Volume by Application: 2021 vs 2025 vs 2032 (Tons)
 Table 34. Global Cannabidiol (CBD) Ingredient Sales Volume by Application (Tons), 2021–2026
 Table 35. Global Cannabidiol (CBD) Ingredient Sales Volume by Application (Tons), 2027–2032
 Table 36. Global Cannabidiol (CBD) Ingredient Sales Market Share in Volume by Application (2021–2026)
 Table 37. Global Cannabidiol (CBD) Ingredient Sales Market Share in Volume by Application (2027–2032)
 Table 38. Global Cannabidiol (CBD) Ingredient Price by Application (US$/Ton), 2021–2026
 Table 39. Global Cannabidiol (CBD) Ingredient Price by Application (US$/Ton), 2027–2032
 Table 40. Global Cannabidiol (CBD) Ingredient Sales Value by Region, (US$ Million), 2021 vs 2025 vs 2032
 Table 41. Global Cannabidiol (CBD) Ingredient Sales Value by Region (US$ Million), 2021–2026
 Table 42. Global Cannabidiol (CBD) Ingredient Sales Value by Region (US$ Million), 2027–2032
 Table 43. Global Cannabidiol (CBD) Ingredient Sales Value by Region (%), 2021–2026
 Table 44. Global Cannabidiol (CBD) Ingredient Sales Value by Region (%), 2027–2032
 Table 45. Global Cannabidiol (CBD) Ingredient Sales Volume by Region (Tons): 2021 vs 2025 vs 2032
 Table 46. Global Cannabidiol (CBD) Ingredient Sales Volume by Region (Tons), 2021–2026
 Table 47. Global Cannabidiol (CBD) Ingredient Sales Volume by Region (Tons), 2027–2032
 Table 48. Global Cannabidiol (CBD) Ingredient Sales Volume by Region (%), 2021–2026
 Table 49. Global Cannabidiol (CBD) Ingredient Sales Volume by Region (%), 2027–2032
 Table 50. Global Cannabidiol (CBD) Ingredient Average Price by Region (US$/Ton), 2021–2026
 Table 51. Global Cannabidiol (CBD) Ingredient Average Price by Region (US$/Ton), 2027–2032
 Table 52. Key Countries/Regions Cannabidiol (CBD) Ingredient Sales Value Growth Trends, (US$ Million): 2021 vs 2025 vs 2032
 Table 53. Key Countries/Regions Cannabidiol (CBD) Ingredient Sales Value, (US$ Million), 2021–2026
 Table 54. Key Countries/Regions Cannabidiol (CBD) Ingredient Sales Value, (US$ Million), 2027–2032
 Table 55. Key Countries/Regions Cannabidiol (CBD) Ingredient Sales Volume, (Tons), 2021–2026
 Table 56. Key Countries/Regions Cannabidiol (CBD) Ingredient Sales Volume, (Tons), 2027–2032
 Table 57. Vantage Hemp Company Information
 Table 58. Vantage Hemp Introduction and Business Overview
 Table 59. Vantage Hemp Cannabidiol (CBD) Ingredient Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)
 Table 60. Vantage Hemp Cannabidiol (CBD) Ingredient Product Offerings
 Table 61. Vantage Hemp Recent Developments
 Table 62. Eurofins Company Information
 Table 63. Eurofins Introduction and Business Overview
 Table 64. Eurofins Cannabidiol (CBD) Ingredient Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)
 Table 65. Eurofins Cannabidiol (CBD) Ingredient Product Offerings
 Table 66. Eurofins Recent Developments
 Table 67. EndoPure Company Information
 Table 68. EndoPure Introduction and Business Overview
 Table 69. EndoPure Cannabidiol (CBD) Ingredient Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)
 Table 70. EndoPure Cannabidiol (CBD) Ingredient Product Offerings
 Table 71. EndoPure Recent Developments
 Table 72. Mile High Labs Company Information
 Table 73. Mile High Labs Introduction and Business Overview
 Table 74. Mile High Labs Cannabidiol (CBD) Ingredient Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)
 Table 75. Mile High Labs Cannabidiol (CBD) Ingredient Product Offerings
 Table 76. Mile High Labs Recent Developments
 Table 77. KLERSUN Company Information
 Table 78. KLERSUN Introduction and Business Overview
 Table 79. KLERSUN Cannabidiol (CBD) Ingredient Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)
 Table 80. KLERSUN Cannabidiol (CBD) Ingredient Product Offerings
 Table 81. KLERSUN Recent Developments
 Table 82. KND Labs Company Information
 Table 83. KND Labs Introduction and Business Overview
 Table 84. KND Labs Cannabidiol (CBD) Ingredient Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)
 Table 85. KND Labs Cannabidiol (CBD) Ingredient Product Offerings
 Table 86. KND Labs Recent Developments
 Table 87. Jordan Process Company Information
 Table 88. Jordan Process Introduction and Business Overview
 Table 89. Jordan Process Cannabidiol (CBD) Ingredient Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)
 Table 90. Jordan Process Cannabidiol (CBD) Ingredient Product Offerings
 Table 91. Jordan Process Recent Developments
 Table 92. GVB Biopharma Company Information
 Table 93. GVB Biopharma Introduction and Business Overview
 Table 94. GVB Biopharma Cannabidiol (CBD) Ingredient Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)
 Table 95. GVB Biopharma Cannabidiol (CBD) Ingredient Product Offerings
 Table 96. GVB Biopharma Recent Developments
 Table 97. Purisys Company Information
 Table 98. Purisys Introduction and Business Overview
 Table 99. Purisys Cannabidiol (CBD) Ingredient Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)
 Table 100. Purisys Cannabidiol (CBD) Ingredient Product Offerings
 Table 101. Purisys Recent Developments
 Table 102. Sanobiotec Company Information
 Table 103. Sanobiotec Introduction and Business Overview
 Table 104. Sanobiotec Cannabidiol (CBD) Ingredient Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)
 Table 105. Sanobiotec Cannabidiol (CBD) Ingredient Product Offerings
 Table 106. Sanobiotec Recent Developments
 Table 107. Folium Biosciences Company Information
 Table 108. Folium Biosciences Introduction and Business Overview
 Table 109. Folium Biosciences Cannabidiol (CBD) Ingredient Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)
 Table 110. Folium Biosciences Cannabidiol (CBD) Ingredient Product Offerings
 Table 111. Folium Biosciences Recent Developments
 Table 112. Colombian Golden Company Information
 Table 113. Colombian Golden Introduction and Business Overview
 Table 114. Colombian Golden Cannabidiol (CBD) Ingredient Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)
 Table 115. Colombian Golden Cannabidiol (CBD) Ingredient Product Offerings
 Table 116. Colombian Golden Recent Developments
 Table 117. Averix Bio, LLC Company Information
 Table 118. Averix Bio, LLC Introduction and Business Overview
 Table 119. Averix Bio, LLC Cannabidiol (CBD) Ingredient Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)
 Table 120. Averix Bio, LLC Cannabidiol (CBD) Ingredient Product Offerings
 Table 121. Averix Bio, LLC Recent Developments
 Table 122. Healthcann Company Information
 Table 123. Healthcann Introduction and Business Overview
 Table 124. Healthcann Cannabidiol (CBD) Ingredient Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)
 Table 125. Healthcann Cannabidiol (CBD) Ingredient Product Offerings
 Table 126. Healthcann Recent Developments
 Table 127. DSM Company Information
 Table 128. DSM Introduction and Business Overview
 Table 129. DSM Cannabidiol (CBD) Ingredient Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)
 Table 130. DSM Cannabidiol (CBD) Ingredient Product Offerings
 Table 131. DSM Recent Developments
 Table 132. Veranova Company Information
 Table 133. Veranova Introduction and Business Overview
 Table 134. Veranova Cannabidiol (CBD) Ingredient Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)
 Table 135. Veranova Cannabidiol (CBD) Ingredient Product Offerings
 Table 136. Veranova Recent Developments
 Table 137. Caesar & Loretz GmbH Company Information
 Table 138. Caesar & Loretz GmbH Introduction and Business Overview
 Table 139. Caesar & Loretz GmbH Cannabidiol (CBD) Ingredient Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)
 Table 140. Caesar & Loretz GmbH Cannabidiol (CBD) Ingredient Product Offerings
 Table 141. Caesar & Loretz GmbH Recent Developments
 Table 142. Recipharm Company Information
 Table 143. Recipharm Introduction and Business Overview
 Table 144. Recipharm Cannabidiol (CBD) Ingredient Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)
 Table 145. Recipharm Cannabidiol (CBD) Ingredient Product Offerings
 Table 146. Recipharm Recent Developments
 Table 147. Brains Bioceutical Company Information
 Table 148. Brains Bioceutical Introduction and Business Overview
 Table 149. Brains Bioceutical Cannabidiol (CBD) Ingredient Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)
 Table 150. Brains Bioceutical Cannabidiol (CBD) Ingredient Product Offerings
 Table 151. Brains Bioceutical Recent Developments
 Table 152. Bedrocan Company Information
 Table 153. Bedrocan Introduction and Business Overview
 Table 154. Bedrocan Cannabidiol (CBD) Ingredient Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)
 Table 155. Bedrocan Cannabidiol (CBD) Ingredient Product Offerings
 Table 156. Bedrocan Recent Developments
 Table 157. BIOVECTRA Inc. Company Information
 Table 158. BIOVECTRA Inc. Introduction and Business Overview
 Table 159. BIOVECTRA Inc. Cannabidiol (CBD) Ingredient Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)
 Table 160. BIOVECTRA Inc. Cannabidiol (CBD) Ingredient Product Offerings
 Table 161. BIOVECTRA Inc. Recent Developments
 Table 162. Biosyyd, UAB Company Information
 Table 163. Biosyyd, UAB Introduction and Business Overview
 Table 164. Biosyyd, UAB Cannabidiol (CBD) Ingredient Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)
 Table 165. Biosyyd, UAB Cannabidiol (CBD) Ingredient Product Offerings
 Table 166. Biosyyd, UAB Recent Developments
 Table 167. Kinetochem Company Information
 Table 168. Kinetochem Introduction and Business Overview
 Table 169. Kinetochem Cannabidiol (CBD) Ingredient Sales (Tons), Revenue (US$ Million), Price (US$/Ton) and Gross Margin (2021–2026)
 Table 170. Kinetochem Cannabidiol (CBD) Ingredient Product Offerings
 Table 171. Kinetochem Recent Developments
 Table 172. Key Raw Materials Lists
 Table 173. Key Suppliers of Raw Materials Lists
 Table 174. Cannabidiol (CBD) Ingredient Downstream Customers
 Table 175. Cannabidiol (CBD) Ingredient Distributors List
 Table 176. Research Programs/Design for This Report
 Table 177. Key Data Information from Secondary Sources
 Table 178. Key Data Information from Primary Sources


List of Figures
 Figure 1. Cannabidiol (CBD) Ingredient Product Picture
 Figure 2. Global Cannabidiol (CBD) Ingredient Sales Value, 2021 vs 2025 vs 2032 (US$ Million)
 Figure 3. Global Cannabidiol (CBD) Ingredient Sales Value (US$ Million), 2021–2032
 Figure 4. Global Cannabidiol (CBD) Ingredient Sales Volume (Tons), 2021–2032
 Figure 5. Global Cannabidiol (CBD) Ingredient Sales Price (US$/Ton), 2021–2032
 Figure 6. Cannabidiol (CBD) Ingredient Report Years Considered
 Figure 7. Global Cannabidiol (CBD) Ingredient Players Revenue Ranking (US$ Million), 2025
 Figure 8. Global Cannabidiol (CBD) Ingredient Sales Volume Ranking of Players (Tons), 2025
 Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Cannabidiol (CBD) Ingredient Revenue in 2025
 Figure 10. Cannabidiol (CBD) Ingredient Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 11. Natural Marijuana-Based Picture
 Figure 12. Synthetic Picture
 Figure 13. Global Cannabidiol (CBD) Ingredient Sales Value by Type (US$ Million), 2021 vs 2025 vs 2032
 Figure 14. Global Cannabidiol (CBD) Ingredient Sales Value Market Share by Type, 2025 & 2032
 Figure 15. Global Cannabidiol (CBD) Ingredient Sales Volume by Type (Tons), 2021 vs 2025 vs 2032
 Figure 16. Global Cannabidiol (CBD) Ingredient Sales Volume Market Share by Type, 2025 & 2032
 Figure 17. Global Cannabidiol (CBD) Ingredient Price by Type (US$/Ton), 2021–2032
 Figure 18. Product Picture of Food and Beverages
 Figure 19. Product Picture of Personal Care and Cosmetics
 Figure 20. Product Picture of Nutraceuticals
 Figure 21. Product Picture of API
 Figure 22. Global Cannabidiol (CBD) Ingredient Sales Value by Application (US$ Million), 2021 vs 2025 vs 2032
 Figure 23. Global Cannabidiol (CBD) Ingredient Sales Value Market Share by Application, 2025 & 2032
 Figure 24. Global Cannabidiol (CBD) Ingredient Sales Volume by Application (Tons), 2021 vs 2025 vs 2032
 Figure 25. Global Cannabidiol (CBD) Ingredient Sales Volume Market Share by Application, 2025 & 2032
 Figure 26. Global Cannabidiol (CBD) Ingredient Price by Application (US$/Ton), 2021–2032
 Figure 27. North America Cannabidiol (CBD) Ingredient Sales Value (US$ Million), 2021–2032
 Figure 28. North America Cannabidiol (CBD) Ingredient Sales Value by Country (%), 2025 vs 2032
 Figure 29. Europe Cannabidiol (CBD) Ingredient Sales Value (US$ Million), 2021–2032
 Figure 30. Europe Cannabidiol (CBD) Ingredient Sales Value by Country (%), 2025 vs 2032
 Figure 31. Asia Pacific Cannabidiol (CBD) Ingredient Sales Value (US$ Million), 2021–2032
 Figure 32. Asia Pacific Cannabidiol (CBD) Ingredient Sales Value by Region (%), 2025 vs 2032
 Figure 33. South America Cannabidiol (CBD) Ingredient Sales Value (US$ Million), 2021–2032
 Figure 34. South America Cannabidiol (CBD) Ingredient Sales Value by Country (%), 2025 vs 2032
 Figure 35. Middle East & Africa Cannabidiol (CBD) Ingredient Sales Value (US$ Million), 2021–2032
 Figure 36. Middle East & Africa Cannabidiol (CBD) Ingredient Sales Value by Country (%), 2025 vs 2032
 Figure 37. Key Countries/Regions Cannabidiol (CBD) Ingredient Sales Value (%), 2021–2032
 Figure 38. Key Countries/Regions Cannabidiol (CBD) Ingredient Sales Volume (%), 2021–2032
 Figure 39. United States Cannabidiol (CBD) Ingredient Sales Value (US$ Million), 2021–2032
 Figure 40. United States Cannabidiol (CBD) Ingredient Sales Value by Type (%), 2025 vs 2032
 Figure 41. United States Cannabidiol (CBD) Ingredient Sales Value by Application (%), 2025 vs 2032
 Figure 42. Europe Cannabidiol (CBD) Ingredient Sales Value (US$ Million), 2021–2032
 Figure 43. Europe Cannabidiol (CBD) Ingredient Sales Value by Type (%), 2025 vs 2032
 Figure 44. Europe Cannabidiol (CBD) Ingredient Sales Value by Application (%), 2025 vs 2032
 Figure 45. China Cannabidiol (CBD) Ingredient Sales Value (US$ Million), 2021–2032
 Figure 46. China Cannabidiol (CBD) Ingredient Sales Value by Type (%), 2025 vs 2032
 Figure 47. China Cannabidiol (CBD) Ingredient Sales Value by Application (%), 2025 vs 2032
 Figure 48. Japan Cannabidiol (CBD) Ingredient Sales Value (US$ Million), 2021–2032
 Figure 49. Japan Cannabidiol (CBD) Ingredient Sales Value by Type (%), 2025 vs 2032
 Figure 50. Japan Cannabidiol (CBD) Ingredient Sales Value by Application (%), 2025 vs 2032
 Figure 51. South Korea Cannabidiol (CBD) Ingredient Sales Value (US$ Million), 2021–2032
 Figure 52. South Korea Cannabidiol (CBD) Ingredient Sales Value by Type (%), 2025 vs 2032
 Figure 53. South Korea Cannabidiol (CBD) Ingredient Sales Value by Application (%), 2025 vs 2032
 Figure 54. Southeast Asia Cannabidiol (CBD) Ingredient Sales Value (US$ Million), 2021–2032
 Figure 55. Southeast Asia Cannabidiol (CBD) Ingredient Sales Value by Type (%), 2025 vs 2032
 Figure 56. Southeast Asia Cannabidiol (CBD) Ingredient Sales Value by Application (%), 2025 vs 2032
 Figure 57. India Cannabidiol (CBD) Ingredient Sales Value (US$ Million), 2021–2032
 Figure 58. India Cannabidiol (CBD) Ingredient Sales Value by Type (%), 2025 vs 2032
 Figure 59. India Cannabidiol (CBD) Ingredient Sales Value by Application (%), 2025 vs 2032
 Figure 60. Cannabidiol (CBD) Ingredient Industrial Chain
 Figure 61. Cannabidiol (CBD) Ingredient Manufacturing Cost Structure
 Figure 62. Channels of Distribution (Direct Sales, and Distribution)
 Figure 63. Bottom-up and Top-down Approaches for This Report
 Figure 64. Data Triangulation
 Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$3950

Single User License
Electronic

$5925

Multi User License
Electronic

$7900

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Samsung SD